Health Catalyst (HCAT) Shares Outstanding (Weighted Average) (2018 - 2026)

Health Catalyst (HCAT) has 9 years of Shares Outstanding (Weighted Average) data on file, last reported at $72.6 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 5.9% year-over-year to $72.6 million; the trailing twelve-month figure through Mar 2026 stood at $72.6 million (up 5.9% YoY), and the FY2025 full-year result was $69.9 million, up 16.14% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $72.6 million, up from $69.9 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $72.6 million in Q1 2026 and bottomed at $53.0 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $58.6 million (2024), against an average of $60.4 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) rose 20.83%; it then rose 3.24% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $53.7 million in 2022, then increased by 5.02% to $56.4 million in 2023, then climbed by 6.68% to $60.2 million in 2024, then increased by 16.14% to $69.9 million in 2025, then advanced by 3.86% to $72.6 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $72.6 million (Q1 2026), $69.9 million (Q4 2025), and $70.4 million (Q3 2025), per Business Quant data.

Peer Comparison